Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.

Şatırtav G, Lövestam-Adrian MK, Chang W, Charles M, Chen LJ, Cheung CMG, Kodjikian L, Ohji M, Zinkernagel M, Wolf S

Open source

DOI
10.2147/opth.s587803
Published
2026
Container
Clinical ophthalmology (Auckland, N.Z.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/opth.s587803,
  title = {Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.},
  author = {Şatırtav G and Lövestam-Adrian MK and Chang W and Charles M and Chen LJ and Cheung CMG and Kodjikian L and Ohji M and Zinkernagel M and Wolf S},
  year = {2026},
  journal = {Clinical ophthalmology (Auckland, N.Z.)},
  doi = {10.2147/opth.s587803},
  url = {https://doi.org/10.2147/opth.s587803}
}

RIS

TY  - JOUR
TI  - Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.
AU  - Şatırtav G
AU  - Lövestam-Adrian MK
AU  - Chang W
AU  - Charles M
AU  - Chen LJ
AU  - Cheung CMG
AU  - Kodjikian L
AU  - Ohji M
AU  - Zinkernagel M
AU  - Wolf S
PY  - 2026
JO  - Clinical ophthalmology (Auckland, N.Z.)
DO  - 10.2147/opth.s587803
UR  - https://doi.org/10.2147/opth.s587803
ER  - 

APA

G, Ş., MK, L., W, C., M, C., LJ, C., CMG, C., L, K., M, O., M, Z., & S, W. (2026). Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.. Clinical ophthalmology (Auckland, N.Z.). https://doi.org/10.2147/opth.s587803

Source records